Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1959 1
1961 1
1964 2
1965 2
1969 1
1972 1
1973 1
1974 2
1975 2
1976 4
1977 1
1978 2
1979 2
1980 1
1982 3
1983 1
1984 5
1985 3
1986 2
1987 3
1988 2
1990 3
1991 2
1992 2
1993 3
1994 3
1995 9
1996 2
1997 4
1998 1
2000 1
2001 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

74 results
Results by year
Filters applied: . Clear all
Page 1
Merbarone: an antitumor agent entering clinical trials.
Glover A, Chun HG, Kleinman LM, Cooney DA, Plowman J, Grieshaber CK, Malspeis L, Leyland-Jones B. Glover A, et al. Among authors: malspeis l. Invest New Drugs. 1987;5(2):137-43. doi: 10.1007/BF00203538. Invest New Drugs. 1987. PMID: 3308762 Review.
Tiazofurin: a new antitumor agent.
O'Dwyer PJ, Shoemaker DD, Jayaram HN, Johns DG, Cooney DA, Marsoni S, Malspeis L, Plowman J, Davignon JP, Davis RD. O'Dwyer PJ, et al. Among authors: malspeis l. Invest New Drugs. 1984;2(1):79-84. doi: 10.1007/BF00173791. Invest New Drugs. 1984. PMID: 6381381 Review.
Plasma pharmacokinetics of genistein in mice.
Supko J, Malspeis L. Supko J, et al. Among authors: malspeis l. Int J Oncol. 1995 Oct;7(4):847-54. doi: 10.3892/ijo.7.4.847. Int J Oncol. 1995. PMID: 21552913
Chemistry of some 3-benzoylpiperidines.
Zalucky TB, Malspeis L, Patel H, Hite G. Zalucky TB, et al. Among authors: malspeis l. J Pharm Sci. 1965 May;54(5):687-93. doi: 10.1002/jps.2600540506. J Pharm Sci. 1965. PMID: 5845879 No abstract available.
Phase I trial of teroxirone.
Neidhart JA, Derocher D, Grever MR, Kraut EH, Malspeis L. Neidhart JA, et al. Among authors: malspeis l. Cancer Treat Rep. 1984 Sep;68(9):1115-9. Cancer Treat Rep. 1984. PMID: 6478450
74 results